Online Program

Overview of cdc's adoption and demonstration of adaptation prevention techniques (ADAPT-2) project: Lessons learned adapting HIV prevention interventions for high-risk adolescent and adult women

Tuesday, November 5, 2013 : 8:30 a.m. - 8:45 a.m.

Jeffrey H. Herbst, PhD, Research and Evaluation Branch, US Centers for Disease Control and Prevention, Atlanta, GA
Deborah Gelaude, MA, Prevention Research Branch, DHAP, NCHHSTP, Centers for Disease Control and Prevention, Atlanta, GA
Amy M. Fasula, MPH, PhD, Division of HIV/AIDS Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, GA
Jerris L. Raiford, PhD, CCID/NCHHSTP/Division of HIV/AIDS Prevention/Program Evaluation Branch, Centers for Disease Control and Prevention, Atlanta, GA
Monique Carry, PhD, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Issues: Evidence-based behavioral interventions (EBIs) are delivered by community-based organizations and other prevention providers to reduce risk behaviors associated with the acquisition or transmission of HIV. EBIs are commonly adapted in real-world settings for the purpose of addressing the unique prevention needs of populations that differ from the original intervention efficacy study. However, there is little empirical evidence that adapted EBIs remain efficacious.

Description: The CDC's Adoption and Demonstration of Adaptation Prevention Techniques (ADAPT-2) project funded research sites from 2007 to 2012 to adapt existing EBIs, and test the efficacy of adapted EBIs delivered in a new setting and/or -to a new population at high risk for acquiring or transmitting HIV. The projects included adapting the following EBIs and new target populations: Horizons for detained African American female adolescents (Project IMARA), Women's CoOp for African American female adolescents at risk of dropping out of school (Young Women's CoOp), and Project S.A.F.E. for incarcerated women (Project P.O.W.E.R.).

Lessons Learned: Each of the sites encountered challenges adapting EBIs even though a systematic adaptation process was implemented. Highlighted challenges include: developing appropriate intervention content while maintaining the core elements of the original EBI, engaging the target population in the adaptation process, and selecting an EBI that addresses the myriad of individual, interpersonal, and structural factors impacting the risk behaviors of the target population.

Recommendations: The ADAPT-2 Project enabled researchers to adapt EBIs for high-risk populations. Lessons learned can be used to instruct HIV prevention providers to adapt EBIs for the populations they serve.

Learning Areas:

Administer health education strategies, interventions and programs
Implementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe CDC’s Adoption and Demonstration of Adaptation Prevention Techniques (ADAPT-2) Project. [Note: Results of the randomized controlled trials will be submitted separately.] Discuss overview of challenges and solutions to adapting evidence-based behavioral interventions (EBIs) for adolescent and adult women at risk for HIV acquisition or transmission. Outline future directions for adaptation of EBIs within the context of high-impact HIV prevention.

Keyword(s): Interventions, Women and HIV/AIDS

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: For the past 10 years, I have served as a Behavioral Scientist in the Prevention Research Branch, Division of HIV/AIDS Prevention at CDC. I conduct behavioral intervention research to prevent HIV/AIDS. I also served as a Research Psychologist at the National Institutes of Health (NIA) for 15 years from 1987 to 2002.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4048.0: HIV interventions for women